Ann: Paragon Care and Quantum Merger - Investor Presentation, page-11

As a QTm shareholder I was a bit frustrated by this news at first. Qtm was and is still deeply undervalued. The Opportunity to grow however, is far greater for both business units, together. This transaction has kept both companies lite on Investor relations, so not many investors would know much of QTm's wins of late.

Once merged I am very confident that the QTm division will deliver on the pent up demand that has been building accross Healthcare sector due to cv19. Companies like AHC IDX have talked about this...as long as they manage the global chip shortage and logistics without cost blow outs...

This merged company will have a far wider attraction to a larger investment universe. It should re rate as the company does just a bit of IR and explanation of what they both do and the cross sell opportunities...
imo

Twinning